Channels of Communication & Brain Functioning: Pilot fMRI Study
COCACE
Canaux de COmmuniCAtion et Fonctionnement du CErveau: Étude Pilote en IRMf
1 other identifier
observational
30
1 country
1
Brief Summary
Communication is a social process involving individuals exchanging messages. It is usual to observe different reactions according to the manner of communication, the manner in which such information is exchanged. In this work, it will be examined how different communication modalities cause different reactions in a person. We make the assumption that each communication modality is based on a different brain network.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2020
CompletedFirst Posted
Study publicly available on registry
August 31, 2020
CompletedStudy Start
First participant enrolled
September 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedNovember 4, 2020
October 1, 2020
12 months
August 27, 2020
November 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in fMRI activity level
Measure the differences in fMRI BOLD activation in healthy subjects while viewing typical videos of four different types of communication channels.
1-day
Eligibility Criteria
Healthy participants, medical students
You may qualify if:
- Healthy volunteers.
- Both sexes (1:1).
- Aged between 20 and 30 years old.
- Medical student, from L2.
- A person who has signed a written, free and informed consent.
- Person affiliated to a social security scheme.
You may not qualify if:
- Current clinically significant psychiatric disorder (MINI 7.0): mood disorder, bipolar disorder, psychotic disorder, substance abuse.
- Current or past neurological disorder with current functional impact.
- Chronic unstable somatic pathology.
- Occasional use of medication other than contraceptives, migraine medication, or analgesics.
- MRI contraindications, including claustrophobia.
- Pregnant or breastfeeding woman.
- Subject deprived of liberty (by a judicial or administrative decision).
- Subject protected by law (subject under guardianship and curatorship).
- Legal incapacity and/or other circumstances rendering the subject incapable of understanding the nature, purpose or consequences of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Tourslead
- Kahler Communication Francecollaborator
Study Sites (1)
Centre Investigation Clinique
Tours, Centre-Val de Loire, 37044, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GISSOT Valérie, MD
CHRU Tours - CIC1415
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2020
First Posted
August 31, 2020
Study Start
September 15, 2020
Primary Completion
September 1, 2021
Study Completion
December 1, 2021
Last Updated
November 4, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share